National Centre for Pharmacoeconomics. (2007) Economic evaluation of the use of Suboxone for opiate addiction. Dublin: National Centre for Pharmacoeconomics.
Preview | Title | Contact |
---|---|---|
|
PDF (Summary)
- Published Version
87kB |
Suboxone cannot be considered a cost effective option for patients attending HSE clinics or in the community setting in Ireland.
Item Type
Report
Publication Type
Irish-related, Report
Drug Type
Opioid
Intervention Type
Drug therapy, Treatment method
Date
2007
Pages
4 p.
Publisher
National Centre for Pharmacoeconomics
Corporate Creators
National Centre for Pharmacoeconomics
Place of Publication
Dublin
EndNote
Accession Number
HRB (Electronic Only)
Related (external) link
Subjects
B Substances > Opioids (opiates)
B Substances > Opioids (opiates) > Opioid product > Buprenorphine / Suboxone
HJ Treatment or recovery method > Substance disorder treatment method > Substance replacement method (substitution)
J Health care, prevention, harm reduction and treatment > Treatment and maintenance > Treatment factors
MP-MR Policy, planning, economics, work and social services > Programme planning, implementation, and evaluation > Programme and budget analysis (cost benefit)
MP-MR Policy, planning, economics, work and social services > Economic aspects of substance use (cost / pricing)
VA Geographic area > Europe > Ireland
B Substances > Opioids (opiates) > Opioid product > Buprenorphine / Suboxone
HJ Treatment or recovery method > Substance disorder treatment method > Substance replacement method (substitution)
J Health care, prevention, harm reduction and treatment > Treatment and maintenance > Treatment factors
MP-MR Policy, planning, economics, work and social services > Programme planning, implementation, and evaluation > Programme and budget analysis (cost benefit)
MP-MR Policy, planning, economics, work and social services > Economic aspects of substance use (cost / pricing)
VA Geographic area > Europe > Ireland
Repository Staff Only: item control page